CureMate:用于乳腺癌治疗的临床决策支持系统
Rodrigo Martín Gómez Del Moral Herranz1, María Jesús López Rodríguez2, Alexander P Seiffert3
1Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Avenida Complutense 30, 28040 Madrid, Spain.
International journal of medical informatics
|October 11, 2024
概括
临床决策支持系统CureMate使用人工智能准确预测最佳初始乳腺癌 (BC) 治疗方案. 该系统由支持矢量机 (SVM) 模型提供动力,帮助临床医生做出明智的治疗决策.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 乳腺癌 (BC) 治疗决策是复杂的,需要考虑多个患者特异性的因素.
- 许多一线治疗选择存在,需要仔细选择以获得最佳的患者结果.
研究的目的:
- 推出CureMate,一个临床决策支持系统 (CDSS),旨在预测乳腺癌患者最有效的初始治疗.
- 该系统利用各种人工智能 (AI) 模型分析人口统计,解剖病理和磁共振成像 (MRI) 数据.
- CureMate有一个用户友好的Web应用程序,可以轻松访问表现最好的AI模型.
主要方法:
- 一个数据集包括232名乳腺癌患者 (BCE) 和29个变量被编制.
- 评估了四种机器学习算法:决策树分类器 (DTC),高斯素朴贝叶斯 (GNB),k-近邻 (K-NN) 和支持向量机器 (SVM).
- 最合适的模型被确定,优化,并独立验证.
主要成果:
- 支持矢量机 (SVM) 模型在乳腺癌治疗规划方面表现出卓越的性能,测试准确度为0.933.
- CureMate 网络应用程序集成了 SVM 模型,允许输入患者变量,以建议最佳的第一个治疗步骤和随后的治疗途径.
结论:
- CureMate具有很高的准确性和临床实用性,为支持医疗保健专业人员为乳腺癌患者做出基于证据的治疗决策提供了显著的潜力.
- 该系统的AI驱动方法可以提高乳腺癌治疗计划的精度和效率.
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:27Nursing Clinical Information System
756
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
756
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:24Kaplan-Meier Approach
103
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103